Waters Corporation Chief Financial Officer to Stand Down
Waters Corporation (Massachusetts, USA) has announced that Chief Financial Officer John Ornell intends to move to a reduced workload and resign from 1 February 2014. Ornell will continue to work for the company in an advisory capacity on a part-time basis. Eugene G. Cassis, currently Corporate Vice President of Worldwide Business Development and Investor Relations, will serve as the company?s interim Chief Financial Officer from 1 February 2014.
Waters Corporation (Massachusetts, USA) has announced that Chief Financial Officer John Ornell intends to move to a reduced workload and resign from 1 February 2014. Ornell will continue to work for the company in an advisory capacity on a part-time basis. Eugene G. Cassis, currently Corporate Vice President of Worldwide Business Development and Investor Relations, will serve as the company’s interim Chief Financial Officer from 1 February 2014.
Douglas A. Berthiaume, Chairman and Chief Executive Officer, said: “I’d like to thank John for his dedication to Waters over the past 23 years and for his many contributions as the company’s CFO for the past 12 years. I am pleased that Gene Cassis will serve the company as interim CFO. Gene brings a wealth of relevant experience and a record of success in key leadership positions while already enjoying close working relationships with our investor base, our banking contacts, and with Waters Executive Committee.”
For more information please visit: www.waters.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
